Crossmark

Nicotinamide mononucleotide protects ovarian function and oocyte developmental competence during chemotherapy

Published Online: 2025-08-23

Authors

Shen, Lin

Li, Hemei

Gong, Xueqi

Zhang, Hanwang

Zhao, Yiqing https://orcid.org/0000-0001-5630-5805
Funding

Funding for this research was provided by:

Wuhan Municipal Science and Technology Bureau (2022020801010535)

Beijing Health Promotion Association (BJHPA-2022-SHZHYX ZHQNYJ-JICH-002)

Tongji Hospital (2020HGRY004)
License Information

Text and Data Mining valid from 2025-08-23

Version of Record valid from 2025-08-23
More Information

Article History

Received: 3 May 2025

Accepted: 7 August 2025

First Online: 23 August 2025

Declarations

:

: This is an animal study. Mouse experiments were conducted following the guidelines and regulations approved by the Institutional Review Board of Tongji Hospital (approval number TJH-202305017). All animal experiments were performed based on the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines. Consent to participate is not applicable.

: The authors declare no competing interests.

: Not applicable.

Document is current